Author: admin

  • 2020 Stem Cell Therapies Grant

    The Medical Research Future Fund (MRFF) – Stem Cell Therapies Mission provides $150 million over 10 years from 2019-20 to support stem cell research to deliver innovative, safe and effective treatments.

    The objective of the 2020 Stem Cell Therapies Grant Opportunity is to prime teams working on ‘proof of concept’ stem cell research targeted towards a health care outcome. Funding for such priming programs will target two priority areas aimed at driving innovation and accelerating implementation into clinical practice:

    • Stem cell therapies
    • New treatments using human tissues made from stem cells

    This grant opportunity is being administrated by NHMRC on behalf of the Commonwealth Department of Health. The total amount available is $6 million.

    The application closing date is 2pm (AWST) Wednesday 4 March, 2020.

    Read more about this grant opportunity. Further information on MRFF and the Stem Cell therapies Missions is available via the Department’s website

  • New Supporting Guide for the Australian Code for the Responsible Conduct of Research

    In December 2019 the NHMRC released the Guide to Managing and Investigating Potential Breaches of the Australian Code for the Responsible Conduct of Research, 2018.

    This Guide supports the implementation of the Australian Code for the Responsible Conduct of Research (the Code), which articulates the broad principles that underpin the responsible conduct of Australian research.

    In particular, this Guide is intended to assist institutions and researchers to adhere to the relevant principles of the Code, including:

    • Principle 4: ‘Fairness in the treatment of others’ which requires researchers to treat fellow researchers and others involved in the research fairly and with respect
    • Principle 7: ‘Accountability for the development, undertaking and reporting of research’
    • Principle 8: ‘Promotion of responsible research practices’ which requires researchers to promote and foster a research culture and environment that supports the responsible conduct of research

    Click here to view the Guide and other supporting documentation for the Code

  • Early stage funding for Allied Health and Health Sciences now open

    Early stage funding for research and practice improvement projects is now open for nursing, midwifery, allied health and health sciences professionals.

    The Chief Nursing and Midwifery Office and the Chief Allied Health Office have collaborated in this initiative to offer support for the professions for early stage research and practice improvement projects.

    Closing date for applications is COB Monday 17 February 2020.

    The following requirements must be met for applications to be considered:

    • A funding proposal must be completed by the principal investigator.
    • The principal investigator must be an employee of the WA health system.
    • The project must align with the WA health system and HSP research priorities.

    Submission
    Nursing and midwifery funding proposals require endorsement and submission by the Director of Nursing and Midwifery. Nursing and midwifery funding proposals are to be submitted via email to Nursing&MidwiferyFellowships@health.wa.gov.au. The Nursing and Midwifery Research Proposal template is available via email (Nursing&MidwiferyFellowships@health.wa.gov.au)

     

    Allied health and health sciences funding proposals require endorsement and submission by the Director of Allied Health or relevant HSP Executive. Allied health and health sciences funding proposals are to be submitted via email to CHPO@health.wa.gov.au. The Allied Health and Health Sciences Research Proposal template is available via email (CHPO@health.wa.gov.au)

  • Researchers Perspectives on Obtaining Biospecimens and Data survey

    The Researcher Perspective on Obtaining Biospecimens and Data (RPOBD) is a national biobanking research project which wants to hear from biospecimen researchers about your practices and what future direction biobanking should go both nationally and locally in Western Australia.

     

    The RPOBD survey would like West Australian health and medical researchers to contribute to an anonymous survey on biospecimen practices and researcher opinions. The survey is designed for researchers who have used, are using, or plan to use biospecimens / data or biobanking services in their research methods. If you’re at the beginning of your health and medical research career or have extensive experience the RPOBD team want to hear from you.

     

    The survey aims to investigate:

    • The needs and opinions of researchers towards current biobanking practices in WA;
    • Researchers’ view on future development or models of biobanks in WA

     

    Responses will allow biobanks, their stakeholders, and funders to understand the research demands for biobanking at a state level, as well as contribute to the national biobanking landscape. The survey will take less than 10 minutes to complete, and it’s planned for aggregate results from the responses of all states to be published.

     

    If you have any questions about the survey or would like any additional information please email Amanda Rush (NSW Health).

     

    Take the survey now

    The survey shuts COB Friday, 13 March 2020

  • RETProgram new online training course: Research Governance Service

    The Research Governance Service (RGS) is an interactive, secure web portal that assists Western Australian public health organisations in managing the ethics and governance processes for human research projects.

    The centralised system enables researchers, sponsors, Human Research Ethics Committees, ethics and governance offices and site administrators to manage and track the governance of research though the entire research project lifecycle. This includes ethics approval, site (also called governance) authorisation, monitoring, complaints, publications and reporting.

    This RGS online training course is designed to assist researchers and sponsors to navigate the RGS through the submission, ethics and governance review and approval processes for proposed projects as well as the monitoring, publications and complaints processes for approved research. It is highly recommended that participants unfamiliar with ethics and governance terminology and processes complete the RETProgram Good Clinical Practice (GCP) course prior to starting this course.

    To learn more about the RGS course and to enroll please visit the RETProgram website.

  • Linkage Projects for Funding in 2020

    The Linkage Projects scheme supports projects which initiate or develop long term strategic research alliances to apply advanced knowledge to problems, acquire new knowledge and as a basis for securing commercial and other benefits of research.

    To facilitate successful collaboration between higher education institutions and other parts of the innovation system, there will be three assessment rounds for Linkage Projects for funding applied for in 2020, an d funding outcomes will be recommended to the Minister within six months of the application closing date for each round.

    The Linkage Projects scheme objectives are to:

    • Support the development of long-term strategic research alliances between higher education organisations and industry and other research end-users, in order to apply advanced knowledge to problems
    • Provide opportunities for internationally competitive research projects to be conducted in collaboration with organisations outside the higher education sector
    • Enhance the scale and focus of research in Australian Government priority areas

    The intended outcomes of the Linkage Projects scheme are:

    • The growth of a national pool of world-class researchers to meet the needs of the broader Australian innovation system
    • Economic, commercial, environmental, social and/or cultural benefits for Australia

    Applications may only be submitted through the Research Office of an Eligible Organisation listed in the Grant Guidelines. The application must nominate at least one Chief Investigator (CI). The first CI will be the Project Leader. Additional CIs and Partner Investigators (PIs) may be nominated in the application.

    The Estimated Grant Value is between $50,000 to $300,000.

    Grant applications close 2pm (AWST), Tuesday 1 December 2020.

    Click here for more information

     

     

  • Kidney Disease Grant Opportunity

    Australia is facing a kidney disease crisis – one in three adults are at risk of chronic kidney disease, one in ten have early signs of disease and more than 1.5 million have no idea they have chronic kidney disease.

    The Action Plan for Kidney Disease Strategy (draft) has three priority areas with nine corresponding objectives and 34 individual action items for implementation by the Australian Government, State and Territories, the healthcare and research sectors and  chronic disease and consumer peak bodies. It’s anticipated the Action Plan will be released in March 2020.

    The Kidney Disease Key Activities grant is to provide optimal care and support for patients, families and carers of those with kidney disease, health professional education and improve research and data on kidney disease.

    To be eligible you must:

    • Have an Australian Business Number (ABN)
    • Be registered for the purposes of GST
    • Be a permanent resident of Australia
    • Have an account with an Australian financial institution

    and be one of the following entity types:

    • A company incorporated in Australia
    • A company incorporated by guarantee
    • An incorporated trustee on behalf of a trust
    • An incorporated association
    • A partnership
    • A join (consortia) application with a lead organisation
    • An Australian local government body
    • An Australian state or territory government body
    • An Aboriginal and/or Torres Strait Islander Corporation registered under the Corporations Act 2006

     

    The total amount available is $2.25 million, with the estimated grant value starting from $250,000.

    Applications close Thursday February 13 at 11am (AWST). Click here for more information

     

  • WA Child Research Fund 2019/20 Now Open

    The WA Department of Health in conjunction with the Channel 7 Telethon Trust has announced the eighth round of the WA Child Research Fund (formerly the Telethon-Perth Children’s Hospital Research Fund) is now open for applications, with funding to be awarded in 2020.

    Funded research activities may be wide-ranging but must address areas of direct significance to child and adolescent health. Research may include basic, clinical, health service, or population health research.

    If you need assistance navigating the new Consumer and Community Involvement criteria please contact the Consumer & Community Health Research Network.

    Click here for further information, along with the Guidelines and Conditions and the Application Form.

    If you have any questions please contact the Research Development Unit.

     

    Closing date is 1pm, Friday 28 February 2020.

  • Prof Fiona Wood appointed to National Science and Technology Council

    Congratulations to Professor Fiona Wood AM who has been appointed to the National Science and Technology Council (NSTC), the Council providing advice to the Prime Minister and other Ministers on science and technology issues facing Australia.

    Professor Wood is Director of the Burns Service of Western Australia, co-founder of the Fiona Wood Foundation, and has a four-year appointment on the NSTC. Professor Wood replaces Professor Ian Frazer AC on the Council, and is well placed to advise the Australian Government with her background as a burns surgeon and researcher.

     

    Read the full media statement

  • Ovarian Cancer Research Grant Opportunity (EPCDR Initiative)

    The Medical Research Future Fund (MRFF) Emerging Priorities and Consumer Driven Research (EPCDR) Initiative aims to enable or support:

    • High quality biomedical, clinical, health services and/or population health research which improves patient care
    • Translation of new discoveries into clinical practice
    • New diagnoses, treatments and cures to those suffering from rare and debilitating conditions
    • Joint collaboration of consumers and researchers in undertaking research in emerging priority areas, and
    • Many Australians with debilitating conditions

     

    The objectives of the 2019 Ovarian Cancer Research grant opportunity aims to:

    • Facilitate innovative, high quality research which will lead to:
      • Improved diagnosis and treatment of ovarian cancer
      • Research which will address the gaps in research, leading to a better understanding of the causes and underlying factors which contribute to the development and progression of ovarian cancer
      • Facilitate consumer involvement in the design and evaluation of the research project (including participation in the conduct of the research)
      • Provide high-quality evidence for the new health treatments and/or drugs (where appropriate)
      • Enable rapid translation of consumer-relevant research into clinical practice, health policy and/or health advice which will lead to positive impacts for consumers
      • Encourage the development of multi-disciplinary research teams which deliver measurable outcomes which are a priority for consumers
      • Encourage collaboration between research teams, policy makers, healthcare funders and the health delivery sector (e.g. education, community, industry and/or healthcare)

     

    The total amount available is $20 million. Applications must be submitted electronically via the Research Grants Management System (RGMS).

    Applications close 2pm (AWST), Wednesday 5 February, 2020. More information